Vorinostat - Latest Advances

Epigenetic analysis in cancer research.

Journal: Methods in cell biology

Published: October 01, 2025

Identifying Drug Repurposing Candidates for CLN3 Targeting Proteomics Expression Profile.

Journal: Proceedings. IEEE International Conference on Bioinformatics and Biomedicine

Published: September 17, 2025

Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1.

Journal: ACS medicinal chemistry letters

Published: August 20, 2025

Mechanistic Insights into Vorinostat as a Repositioned Modulator of TACE-Mediated TNF-α Signaling via MAPK and NFκB Pathways.

Journal: Current issues in molecular biology

Published: July 29, 2025

Exploring the binding interaction between triazoles and bromelain by spectroscopic and molecular docking techniques.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: July 23, 2025

Regulation of PD-L1 Expression by SAHA-Mediated Histone Deacetylase Inhibition in Lung Cancer Cells.

Journal: Cancers

Published: July 16, 2025

AI-assisted Drug Re-purposing for Human Liver Fibrosis.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.

Journal: International journal of molecular sciences

Published: July 08, 2025

DSCC1 as a Novel Biomarker in Hepatocellular Carcinoma: Diagnostic Potential, Prognostic Impact, Correlation With Key Pathways, and Association With the Immune Landscape.

Journal: The journal of gene medicine

Published: July 08, 2025

Heteroaryl-Capped Hydroxamic Acid Derivatives with Varied Linkers: Synthesis and Anticancer Evaluation with Various Apoptosis Analyses in Breast Cancer Cells, Including Docking, Simulation, DFT, and ADMET Studies.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 03, 2025

Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.

Journal: Journal of Alzheimer's disease : JAD

Published: July 02, 2025

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 23, 2025

Filters

Epigenetic analysis in cancer research.

Epigenetic analysis in cancer research.

Identifying Drug Repurposing Candidates for CLN3 Targeting Proteomics Expression Profile.

Identifying Drug Repurposing Candidates for CLN3 Targeting Proteomics Expression Profile.

Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1.

Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1.

Mechanistic Insights into Vorinostat as a Repositioned Modulator of TACE-Mediated TNF-α Signaling via MAPK and NFκB Pathways.

Mechanistic Insights into Vorinostat as a Repositioned Modulator of TACE-Mediated TNF-α Signaling via MAPK and NFκB Pathways.

Exploring the binding interaction between triazoles and bromelain by spectroscopic and molecular docking techniques.

Exploring the binding interaction between triazoles and bromelain by spectroscopic and molecular docking techniques.

Regulation of PD-L1 Expression by SAHA-Mediated Histone Deacetylase Inhibition in Lung Cancer Cells.

Regulation of PD-L1 Expression by SAHA-Mediated Histone Deacetylase Inhibition in Lung Cancer Cells.

AI-assisted Drug Re-purposing for Human Liver Fibrosis.

AI-assisted Drug Re-purposing for Human Liver Fibrosis.

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.

DSCC1 as a Novel Biomarker in Hepatocellular Carcinoma: Diagnostic Potential, Prognostic Impact, Correlation With Key Pathways, and Association With the Immune Landscape.

DSCC1 as a Novel Biomarker in Hepatocellular Carcinoma: Diagnostic Potential, Prognostic Impact, Correlation With Key Pathways, and Association With the Immune Landscape.

Heteroaryl-Capped Hydroxamic Acid Derivatives with Varied Linkers: Synthesis and Anticancer Evaluation with Various Apoptosis Analyses in Breast Cancer Cells, Including Docking, Simulation, DFT, and ADMET Studies.

Heteroaryl-Capped Hydroxamic Acid Derivatives with Varied Linkers: Synthesis and Anticancer Evaluation with Various Apoptosis Analyses in Breast Cancer Cells, Including Docking, Simulation, DFT, and ADMET Studies.

Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.

Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.